$10.12

+0.81 (+8.70%)

Weekly Expected Move ±10.3%

$7 $8 $9 $10 $11

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $248.0M mcap · 15M float · 1.21% daily turnover · Short 59% of daily vol

Credit Risk of going bust: higher than 72% of companies Debt: 13.0% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.23 (down 98%), Lyell Immunopharma, Inc. would be worth roughly what it owes.
Total debt $36.9M against a stock market value of $248.0M.
Distance to default 3.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.5M (short-term plus half of long-term), stock volatility 79.5%; Altman Z'' -16.22. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

34.7 / 100

NoneWeakNarrowWide

Primary source: Intangible Assets · ROIC: -227.7% · 5Y Avg: -113.2%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LYEL has No discernible competitive edge (34.7/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -227.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$34

Low

$34

Avg Target

$34

High

Based on 1 analyst since Aug 6, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 3Hold: 3Sell: 1Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$34.00

Analysts1

Consensus Change History

Date	Field	From	To
2026-06-17	consensus	Hold	Buy

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-14	RBC Capital	—	Initiated	$34	—	+147.5%	$13.74
2026-06-03	Needham	—	$44	$45	+1	+202.2%	$14.89
2026-04-30	Robert W. Baird	—	Initiated	$49	—	+148.4%	$19.73
2026-04-10	Needham	—	Initiated	$44	—	+85.0%	$23.79
2025-12-09	H.C. Wainwright	—	$20	$45	+25	+58.7%	$28.36
2025-11-24	H.C. Wainwright	—	Initiated	$20	—	+4.5%	$19.13
2024-10-30	Bank of America Securities	Geoff Meacham	Initiated	$1	—	+5.5%	$0.95
2022-11-14	Morgan Stanley	—	Initiated	$7	—	+54.5%	$4.53
2022-05-24	Goldman Sachs	—	Initiated	$12	—	+199.3%	$4.01

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LYEL receives an overall rating of C+. Strongest factors: P/B (4/5). Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-07-01	C	C+
2026-06-16	C+	C
2026-05-20	C	C+
2026-05-18	C+	C
2026-05-14	C	C+
2026-04-01	C+	C
2026-03-13	C	C+
2026-03-12	C+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 24 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LYEL scores highest in Balance Sheet (87/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

-7.02

Distress Zone

Piotroski F-Score

3/9

✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✗

Beneish M-Score

-4.72

Unlikely Manipulator

Ohlson O-Score

-3.31

Bankruptcy prob: 3.5%

Low Risk

Credit Rating

Score: 43.8/100

Trend: Stable

Earnings Quality

—

OCF/NI: 0.54x

Accruals: -33.1%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LYEL scores -7.02, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LYEL scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LYEL's score of -4.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LYEL's implied 3.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LYEL receives an estimated rating of BB (score: 43.8/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-0.63x

PEG

0.00x

P/S

9184.87x

P/B

1.01x

P/FCF

-2.45x

P/OCF

—

EV/EBITDA

-0.67x

EV/Revenue

5966.53x

EV/EBIT

-0.65x

EV/FCF

-1.20x

Earnings Yield

-75.69%

FCF Yield

-40.81%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LYEL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.000

NI / EBT

Interest Burden

1.000

EBT / EBIT

EBIT Margin

-9202.852

EBIT / Rev

Asset Turnover

0.000

Rev / Assets

Equity Multiplier

1.308

Assets / Equity

ROE

-93.3%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LYEL's ROE of -93.3% is driven by Asset Turnover (0.000), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1347 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$10.12

Median 1Y

$3.46

5th Pctile

$0.76

95th Pctile

$16.12

Ann. Volatility

91.9%

Analyst Target

$34.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Lynn Seely, M.D. President, Chief Executive Officer and Director	$690,173	$186,806	$4,222,265
Stephen Hill Operating rating Officer	$529,473	$62,269	$2,076,439
Gary Lee, Ph.D. Chief Scientific Officer	$520,015	$62,269	$1,942,621

CEO Pay Ratio

15:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $4,222,265

Avg Employee Cost (SGA/emp): $280,342

Employees: 161

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

161

-46.3% YoY

Revenue / Employee

$224

Rev: $36,000

Profit / Employee

$-1,704,646

NI: $-274,448,000

SGA / Employee

$280,342

Avg labor cost proxy

R&D / Employee

$985,559

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-11.3%	-21.0%	-29.9%	-25.1%	-28.6%	-20.8%	-21.9%	-26.1%	-25.1%	-31.5%	-32.9%	-32.3%	-33.2%	-66.1%	-71.2%	-76.6%	-75.8%	-87.0%	-80.8%	-93.3%	-93.28%
ROA	-9.3%	-17.3%	-24.6%	-21.1%	-23.8%	-17.7%	-18.6%	-22.6%	-21.5%	-27.8%	-29.0%	-28.2%	-28.8%	-55.3%	-59.5%	-63.8%	-63.4%	-66.1%	-63.1%	-71.3%	-71.34%
ROIC	-20.4%	-33.1%	-54.5%	-58.2%	-74.4%	-57.7%	-61.2%	-81.2%	-87.5%	-1.2%	-1.4%	-1.3%	-1.2%	-4.0%	-3.1%	-3.6%	-5.0%	-3.7%	-2.2%	-2.3%	-2.28%
ROCE	-9.8%	-18.1%	-25.6%	-24.4%	-27.9%	-20.3%	-21.4%	-26.2%	-25.0%	-32.8%	-33.7%	-33.8%	-35.9%	-50.4%	-57.2%	-62.0%	-54.4%	-97.2%	-79.5%	-91.6%	-91.59%
Gross Margin	1.0%	-41.4%	-6.2%	89.6%	-1389.7%	90.5%	-76.3%	-167.1%	-203.2%	-388.0%	1.0%	1.0%	1.0%	1.0%	1.0%	1.0%	1.0%	1.0%	-1165.0%	1.0%	1.00%
Operating Margin	-17.8%	-17.1%	-127.8%	-1.0%	-22229.3%	-33.1%	-991.6%	-2439.6%	-2423.1%	-4602.3%	-18525.0%	-3963.7%	-1485.4%	-18286.1%	-8195.3%	-5892.5%	-2483.5%	-10218.7%	-23078.5%	-11834.2%	-11834.25%
Net Margin	-17.7%	-29.7%	-123.2%	-1.0%	-23418.0%	-17.4%	-1030.1%	-2366.3%	-2034.1%	-4071.5%	-20222.3%	-3523.8%	-1311.3%	-17448.6%	-7456.4%	-5335.5%	-2589.7%	-23453.8%	-12076.5%	-11188.8%	-11188.75%
EBITDA Margin	-16.4%	-28.2%	-116.0%	-91.2%	-22027.3%	-7.9%	-952.8%	-2198.2%	-1830.0%	-3682.5%	-16850.3%	-3586.7%	-1347.8%	-5240.0%	-7703.7%	-5320.2%	-2418.7%	-23054.3%	-10910.5%	-10633.2%	-10633.25%
FCF Margin	-17.7%	-16.9%	-22.4%	-4.5%	-4.9%	-2.3%	-2.2%	-3.6%	-3.5%	-1279.8%	-2363.0%	-2944.7%	-2479.9%	-2669.8%	-2704.6%	-2866.6%	-4037.4%	-4189.0%	-4336.1%	-4961.9%	-4961.89%
OCF Margin	-11.0%	-11.3%	-16.0%	-3.6%	-4.2%	-2.0%	-2.0%	-3.4%	-3.4%	-1259.2%	-2345.6%	-2933.9%	-2472.8%	-2662.2%	-2694.1%	-2858.0%	-4024.8%	-4167.3%	-4316.0%	-4935.6%	-4935.56%
ROE 3Y Avg	snapshot only																				-84.75%
ROE 5Y Avg	snapshot only																				-62.00%
ROA 3Y Avg	snapshot only																				-65.99%
ROIC 3Y Avg	snapshot only																				-1.47%
ROIC Economic	snapshot only																				-56.04%
Cash ROA	snapshot only																				-42.83%
Cash ROIC	snapshot only																				-2.00%
CROIC	snapshot only																				-2.01%
NOPAT Margin	snapshot only																				-5619.50%
Pretax Margin	snapshot only																				-9202.85%
R&D / Revenue	snapshot only																				5796.26%
SGA / Revenue	snapshot only																				1497.56%
SBC / Revenue	snapshot only																				1308.63%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-31.84	-9.63	-4.68	-6.77	-7.04	-4.73	-3.24	-3.80	-1.94	-2.09	-2.48	-1.76	-1.73	-0.50	-0.47	-0.39	-0.91	-1.92	-1.78	-1.32	-0.632
P/S Ratio	659.27	228.98	140.80	38.35	46.53	10.23	7.00	16.41	7.62	3776.82	8337.97	6857.91	5614.39	2796.47	2442.50	2179.50	7235.91	14614.51	14155.89	12157.93	9184.875
P/B Ratio	3.60	2.02	1.40	1.85	2.22	1.04	0.75	1.08	0.53	0.75	0.94	0.65	0.67	0.45	0.47	0.44	0.90	2.12	1.60	1.40	1.011
P/FCF	-37.17	-13.52	-6.27	-8.47	-9.46	-4.47	-3.20	-4.61	-2.17	-2.95	-3.53	-2.33	-2.26	-1.05	-0.90	-0.76	-1.79	-3.49	-3.26	-2.45	-2.450
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBITDA	-28.59	-7.22	-2.76	-4.59	-5.10	-1.76	-0.26	-1.39	0.83	-0.04	-0.50	0.32	0.15	0.70	0.42	0.45	-0.11	-1.18	-0.98	-0.67	-0.674
EV/Revenue	556.50	162.32	78.40	24.28	31.61	3.47	0.51	5.49	-2.91	61.01	1507.47	-1121.68	-448.66	-2311.05	-1312.70	-1515.21	520.32	8911.76	7537.44	5966.53	5966.526
EV/EBIT	-26.78	-6.81	-2.60	-4.28	-4.79	-1.60	-0.24	-1.27	0.74	-0.03	-0.46	0.29	0.13	0.64	0.38	0.42	-0.10	-1.14	-0.94	-0.65	-0.648
EV/FCF	-31.37	-9.59	-3.49	-5.36	-6.43	-1.51	-0.23	-1.54	0.83	-0.05	-0.64	0.38	0.18	0.87	0.49	0.53	-0.13	-2.13	-1.74	-1.20	-1.202
Earnings Yield	-3.1%	-10.4%	-21.4%	-14.8%	-14.2%	-21.1%	-30.9%	-26.3%	-51.5%	-47.8%	-40.3%	-56.8%	-57.7%	-2.0%	-2.1%	-2.5%	-1.1%	-52.2%	-56.2%	-75.7%	-75.69%
FCF Yield	-2.7%	-7.4%	-15.9%	-11.8%	-10.6%	-22.4%	-31.2%	-21.7%	-46.2%	-33.9%	-28.3%	-42.9%	-44.2%	-95.5%	-1.1%	-1.3%	-55.8%	-28.7%	-30.6%	-40.8%	-40.81%
PEG Ratio	snapshot only																				0.005
Price/Tangible Book	snapshot only																				1.404
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	10.65	13.40	15.24	13.26	12.88	17.59	20.27	17.63	16.74	16.07	16.51	16.19	13.43	7.06	7.49	7.65	10.30	5.28	7.23	5.36	5.356
Quick Ratio	10.65	13.40	15.24	13.26	12.88	17.59	20.27	17.63	16.74	16.07	16.51	16.19	13.43	7.06	7.49	7.65	10.30	5.28	7.23	5.36	5.356
Debt/Equity	0.07	0.07	0.08	0.08	0.08	0.08	0.09	0.09	0.09	0.10	0.10	0.11	0.11	0.15	0.17	0.18	0.13	0.17	0.18	0.16	0.158
Net Debt/Equity	-0.56	-0.59	-0.62	-0.68	-0.71	-0.69	-0.70	-0.72	-0.73	-0.74	-0.77	-0.76	-0.72	-0.81	-0.73	-0.74	-0.84	-0.83	-0.75	-0.71	-0.715
Debt/Assets	0.05	0.06	0.06	0.06	0.07	0.07	0.08	0.08	0.08	0.08	0.09	0.09	0.09	0.12	0.13	0.14	0.11	0.12	0.14	0.12	0.119
Debt/EBITDA	-0.63	-0.37	-0.27	-0.30	-0.27	-0.41	-0.41	-0.35	-0.38	-0.29	-0.30	-0.32	-0.31	-0.29	-0.28	-0.28	-0.23	-0.15	-0.20	-0.15	-0.155
Net Debt/EBITDA	5.28	2.96	2.20	2.66	2.41	3.44	3.32	2.77	2.99	2.25	2.28	2.26	2.00	1.55	1.20	1.11	1.45	0.76	0.86	0.70	0.700
Interest Coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.21	1.21	1.22	1.18	1.19	1.13	1.12	1.13	1.14	1.15	1.15	1.15	1.17	1.28	1.28	1.29	1.24	1.37	1.28	1.33	1.331
Cash Ratio	snapshot only																				5.120
Cash to Debt	snapshot only																				5.526
FCF to Debt	snapshot only																				-3.627
Defensive Interval	snapshot only																				392.6 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.00	0.01	0.01	0.04	0.04	0.08	0.09	0.05	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables Turnover	0.00	1.24	1.22	2.57	3.81	4.62	2.86	3.65	4.21	4.52	2.77	2.03	1.27	0.00	0.00	0.00	0.00	0.00	0.51	0.64	0.643
DSO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DIO	—	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	0	0	0.0 days
DPO	—	293	298	142	96	79	128	100	87	81	132	180	287	—	—	—	—	—	720	568	568.0 days
Cash Conversion Cycle	—	-293	-298	-142	-96	-79	-128	-100	-87	-81	-132	-180	-287	—	—	—	—	—	-720	-568	-568.0 days
Fixed Asset Turnover	snapshot only																				0.001
Cash Velocity	snapshot only																				0.000
Capital Intensity	snapshot only																				11524.185

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	—	—	14.9%	6.3%	9.3%	8.6%	15.8%	24.0%	-99.8%	-99.9%	-99.9%	-99.9%	-53.1%	-4.4%	11.1%	-34.9%	-41.0%	-52.3%	-55.0%	-55.00%
Net Income	—	—	—	-2.8%	-1.3%	6.2%	30.9%	11.6%	26.4%	-28.1%	-25.5%	-0.4%	-7.3%	-46.2%	-46.5%	-57.6%	-59.6%	20.0%	26.3%	25.0%	25.02%
EPS	—	—	—	-2.7%	-1.2%	8.7%	32.4%	13.0%	27.3%	-26.3%	-23.2%	1.7%	-5.2%	-38.8%	-26.2%	-36.1%	-12.0%	37.6%	50.3%	52.5%	52.53%
FCF	—	—	—	-2.2%	-1.0%	-39.5%	6.4%	9.0%	11.4%	14.2%	12.7%	7.9%	8.4%	2.1%	-9.4%	-8.2%	-6.0%	7.4%	23.5%	22.1%	22.11%
EBITDA	—	—	—	-2.7%	-1.3%	9.7%	33.9%	13.7%	29.6%	-29.0%	-23.8%	0.2%	-11.7%	6.6%	-0.2%	-4.8%	0.2%	-35.1%	-17.1%	-19.5%	-19.51%
Op. Income	—	—	—	-2.3%	-99.1%	-18.9%	20.2%	-3.8%	7.1%	-31.7%	-31.3%	-6.8%	-5.1%	-43.1%	-49.1%	-56.5%	-57.7%	43.4%	46.8%	46.1%	46.07%
OCF Growth	snapshot only																				22.29%
Asset Growth	snapshot only																				-19.28%
Equity Growth	snapshot only																				-21.78%
Debt Growth	snapshot only																				-32.98%
Shares Change	snapshot only																				57.94%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	—	—	—	—	—	—	—	—	—	—	—	-72.6%	-77.3%	-80.5%	-80.5%	-88.7%	-89.8%	-92.5%	-92.8%	-91.8%	-91.77%
Revenue 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-60.0%	-59.97%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	-75.6%	-56.6%	-87.4%	-87.9%	-91.9%	—	—	—
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	—	—	—	—	—	—	—	—	—	—	—	-19.0%	-19.8%	-24.2%	-26.3%	-27.7%	-25.3%	-28.7%	-26.4%	-28.0%	-28.05%
Assets 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-24.0%	-24.03%
Equity 3Y	—	—	—	—	—	—	—	—	—	—	—	-17.9%	-18.7%	-25.6%	-27.4%	-29.9%	-26.2%	-33.2%	-29.6%	-31.8%	-31.79%
Book Value 3Y	—	—	—	—	—	—	—	—	—	—	—	-19.7%	-20.5%	-27.9%	-31.9%	-34.1%	-35.1%	-39.9%	-41.6%	-44.6%	-44.61%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	—	—	—	—	—	—	0.86	0.90	0.01	0.01	0.00	0.00	0.12	0.12	0.73	0.70	0.60	0.60	0.08	0.078
Earnings Stability	—	—	—	—	—	—	—	0.61	0.29	0.54	0.18	0.46	0.20	0.77	0.27	0.70	0.55	0.60	0.11	0.55	0.547
Margin Stability	—	—	—	—	—	—	—	0.75	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Rev. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.500
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	—	—	—	—	—	—	—	0.95	0.89	0.89	0.90	1.00	0.97	0.82	0.81	0.50	0.50	0.92	0.89	0.90	0.900
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	—	—	—	—	—	—	—	-0.12	-0.06	-0.14	-0.11	-0.09	-0.09	-0.61	-0.69	-0.78	-0.66	-0.48	-0.21	-0.32	-0.323
Gross Margin Trend	—	—	—	—	—	—	—	-0.24	-0.19	-151.41	-215.62	-187.84	-79.87	75.97	108.19	94.27	40.33	75.87	32.86	7.71	7.713
FCF Margin Trend	—	—	—	—	—	—	—	9.81	7.81	-1270.24	-2350.64	-2940.62	-2475.66	-2028.74	-1521.98	-1392.50	-2795.74	-2214.18	-1802.34	-2056.25	-2056.247
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.53	0.47	0.53	0.64	0.63	0.93	0.92	0.78	0.86	0.70	0.70	0.75	0.76	0.47	0.52	0.52	0.51	0.55	0.54	0.54	0.536
FCF/OCF	1.61	1.50	1.40	1.26	1.18	1.14	1.10	1.06	1.04	1.02	1.01	1.00	1.00	1.00	1.00	1.00	1.00	1.01	1.00	1.01	1.005
FCF/Net Income	snapshot only																				0.539
CapEx/Revenue	6.7%	5.6%	6.4%	92.6%	76.6%	28.7%	19.1%	20.3%	14.9%	20.7%	17.4%	10.8%	7.1%	7.6%	10.5%	8.6%	12.7%	21.7%	20.1%	26.3%	26.33%
CapEx/Depreciation	snapshot only																				0.075
Accruals Ratio	-0.04	-0.09	-0.11	-0.08	-0.09	-0.01	-0.01	-0.05	-0.03	-0.08	-0.09	-0.07	-0.07	-0.29	-0.28	-0.31	-0.31	-0.30	-0.29	-0.33	-0.331
Sloan Accruals	snapshot only																				-0.233
Cash Flow Adequacy	snapshot only																				-187.426

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-11.0%	-21.2%	-32.6%	-0.7%	-0.9%	-1.3%	-1.4%	-1.0%	-0.9%	-0.4%	-0.4%	-0.5%	-0.5%	-0.8%	-0.8%	-0.5%	-17.1%	-9.6%	-23.3%	-16.0%	-15.98%
Total Shareholder Return	-11.0%	-21.2%	-32.6%	-0.7%	-0.9%	-1.3%	-1.4%	-1.0%	-0.9%	-0.4%	-0.4%	-0.5%	-0.5%	-0.8%	-0.8%	-0.5%	-17.1%	-9.6%	-23.3%	-16.0%	-15.98%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.02	1.00	0.97	1.56	1.51	1.53	1.59	0.97	0.99	1.00	1.000
EBIT Margin	-20.78	-23.84	-30.11	-5.67	-6.61	-2.16	-2.16	-4.32	-3.92	-1804.86	-3283.06	-3905.30	-3341.87	-3611.05	-3416.40	-3603.92	-4989.66	-7850.92	-8045.77	-9202.85	-9202.852
Asset Turnover	0.00	0.01	0.01	0.04	0.04	0.08	0.09	0.05	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Equity Multiplier	1.21	1.21	1.22	1.19	1.20	1.17	1.17	1.16	1.17	1.13	1.14	1.14	1.15	1.20	1.20	1.20	1.19	1.32	1.28	1.31	1.308

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-9.30	$-16.08	$-21.57	$-19.25	$-20.81	$-14.67	$-14.58	$-16.75	$-15.13	$-18.54	$-17.96	$-16.47	$-15.92	$-25.74	$-22.67	$-22.40	$-17.83	$-16.06	$-11.26	$-10.64	$-10.64
Book Value/Share	$82.28	$76.61	$72.18	$70.48	$66.05	$66.78	$62.81	$58.90	$55.51	$51.76	$47.45	$44.36	$41.41	$28.73	$22.81	$20.21	$18.02	$14.52	$12.51	$10.01	$10.01
Tangible Book/Share	$82.28	$76.61	$72.18	$70.48	$66.05	$66.78	$62.81	$58.90	$55.51	$51.76	$47.45	$44.36	$41.41	$28.73	$22.81	$20.21	$18.02	$14.52	$12.51	$10.01	$10.01
Revenue/Share	$0.45	$0.68	$0.72	$3.40	$3.15	$6.79	$6.75	$3.88	$3.86	$0.01	$0.01	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
FCF/Share	$-7.96	$-11.45	$-16.10	$-15.40	$-15.50	$-15.53	$-14.74	$-13.80	$-13.57	$-13.15	$-12.64	$-12.45	$-12.19	$-12.22	$-11.91	$-11.63	$-9.06	$-8.82	$-6.14	$-5.73	$-5.73
OCF/Share	$-4.96	$-7.63	$-11.51	$-12.25	$-13.08	$-13.59	$-13.46	$-13.01	$-13.00	$-12.94	$-12.55	$-12.41	$-12.16	$-12.19	$-11.87	$-11.59	$-9.03	$-8.78	$-6.12	$-5.70	$-5.70
Cash/Share	$51.62	$50.65	$50.28	$53.23	$52.20	$51.30	$49.10	$47.62	$45.79	$43.17	$41.40	$38.46	$34.38	$27.80	$20.41	$18.71	$17.50	$14.46	$11.61	$8.74	$8.74
EBITDA/Share	$-8.74	$-15.20	$-20.37	$-17.99	$-19.54	$-13.36	$-13.17	$-15.28	$-13.60	$-16.98	$-16.01	$-14.94	$-14.89	$-15.06	$-13.83	$-13.52	$-10.42	$-15.86	$-10.92	$-10.23	$-10.23
Debt/Share	$5.48	$5.59	$5.53	$5.37	$5.21	$5.43	$5.34	$5.28	$5.14	$4.99	$4.86	$4.72	$4.57	$4.42	$3.87	$3.73	$2.42	$2.45	$2.23	$1.58	$1.58
Net Debt/Share	$-46.14	$-45.07	$-44.76	$-47.87	$-47.00	$-45.88	$-43.76	$-42.34	$-40.65	$-38.17	$-36.54	$-33.74	$-29.81	$-23.38	$-16.54	$-14.99	$-15.07	$-12.01	$-9.38	$-7.15	$-7.15

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7.016
Altman Z-Prime	snapshot only																				-14.938
Piotroski F-Score	2	2	2	3	3	4	4	4	5	1	2	2	2	2	2	2	1	2	2	3	3
Beneish M-Score	—	—	—	8.48	-198.45	10.95	-4.78	-146.54	6.87	-324.36	-47.43	-92.46	-110.35	-209.91	-2.07	-4.19	-5.26	-4.82	-5.56	-4.72	-4.722
Ohlson O-Score	snapshot only																				-3.308
ROIC (Greenblatt)	snapshot only																				-1.12%
Net-Net WC	snapshot only																				$5.83
EVA	snapshot only																				$-158391310.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BB
Credit Score	72.96	74.15	61.33	75.72	75.62	76.84	64.25	70.53	49.64	49.50	53.81	44.11	44.40	43.95	44.04	44.16	44.13	43.86	44.26	43.78	43.781
Credit Grade	snapshot only																				12
Credit Trend	snapshot only																				-0.378
Implied Spread (bps)	snapshot only																				475.000
Industry Credit Rank	snapshot only																				40
Sector Credit Rank	snapshot only																				35

LYEL NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet